NASDAQ: DXR - Daxor Corporation

Yield per half year: -18.01%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Daxor Corporation


About Daxor Corporation

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.


IPO date 1992-03-17
ISIN US2394671034
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 1.31
Дивиденд ао 0.06
Сайт https://www.daxor.com
Цена ао 8.06
Change price per day: -5.84% (7.95)
Change price per week: -2.94% (7.713)
Change price per month: -6.07% (7.97)
Change price per 3 month: -9.37% (8.26)
Change price per half year: -18.01% (9.13)
Change price per year: -22.13% (9.6135)
Change price per 3 year: -33.75% (11.3)
Change price per 5 year: -38.49% (12.17)
Change price per year to date: -16.08% (8.92)

Underestimation

Title Value Grade
P/S 1.07 9
P/BV 1.09 9
P/E 132.02 1
EV/EBITDA 114.65 1
Total: 6.13

Efficiency

Title Value Grade
ROA, % 0.8048 1
ROE, % 0.8252 1
Total: 0.6667

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.6429 6.43
Total: 2.58

Debt

Title Value Grade
Debt/EBITDA 2.29 6
Total: 7.4

Growth impulse

Title Value Grade
Yield Revenue, % -242.11 0
Yield Ebitda, % -166.48 0
Yield EPS, % -145.8 0
Total: 0



Head Job title Payment Year of birth
Mr. Michael Richard Feldschuh Chairman, President & CEO 100k 1969 (56 years)
Mr. Jonathan Adam Feldschuh Chief Scientific Officer & Director 127.92k 1965 (60 years)
Mr. Robert J. Michel CPA, CPA, M.B.A. CFO, Chief Compliance Officer & Corporate Secretary N/A 1957 (68 years)
Ms. Linda Cooper Vice President of Development & Operations N/A
Ms. Kathryn A. Kornafel Senior VP of Marketing & Commercial Development N/A
Mr. Guido Manzo Vice President of Sales N/A
Ms. Jean Oertel Senior Vice President Commercialization & Customer Experience N/A
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. Chief Medical Officer

Address: United States, Oak Ridge. TN, 109 Meco Lane - open in Google maps, open in Yandex maps
Website: https://www.daxor.com